Analystreport

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $178.00 price target on th...

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com